From the authors

European Respiratory Journal

Volumn 44, Issue 4, 2014, Pages 1095-1096

  Denkinger, Claudia M ^a,b,c   Pai, Madhukar ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRIFUGATION; CEREBROSPINAL FLUID; CLINICAL PROTOCOL; EXTRAPULMONARY TUBERCULOSIS; HUMAN; LETTER; LYMPH NODE; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TUBERCULOUS MENINGITIS; WORLD HEALTH ORGANIZATION; TUBERCULOSIS;

HUMANS; TUBERCULOSIS;

EID: 84907556337     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00106914     Document Type: Letter

References (5)

1. Denkinger CM, Schumacher SG, Boehme CC, et al. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J 2014; 44: 435-446.
2. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system for the diagnosis of pulmonary and extrapulmonary TB in adults and children. Geneva, WHO, 2013.
3. Weyer K, Mirzayev F, Migliori GB, et al. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J 2013; 42: 252-271.
4. World Health Organization. The use of the Xpert MTB/RIF assay for the detection of pulmonary and extrapulmonary tuberculosis and rifampicin resistance in adults and children. Geneva, WHO, 2014.
5. World Health Organization. Xpert MTB/RIF implementation manual. Technical and operational ''how-to''; practical considerations. Geneva, WHO, 2014.